Publications

De resistentie van hiv tegen een van de meest gebruikte aidsremmers, tenofovir, neemt toe. Dat blijkt uit een meta-analyse gepubliceerd in The Lancet Infectious Diseases. Eerder deze week noemde eerste auteur dr. Ravi Gupta de resultaten tegenover de BBC ‘zeer zorgwekkend’. De Nederlandse internist-infectioloog in opleiding...

Potent tenofovir-containing antiretroviral regimens are increasingly used to treat and prevent HIV. Few data exist on the frequency of and risk factors for acquired drug resistance in regions hardest hit by the HIV pandemic. This collaborative study combined data from adult treatment cohorts and clinical...

Without antiretroviral treatment (ART), half of all children born with HIV will die before the age of two years. Although increasing numbers of children in resource-limited settings now have access to ART, important challenges remain. The World Health Organization recommends the use of protease inhibitors for...

Constance Schultsz et al. did a prospective study of acquisition of fecal colonisation and carriage with extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in 2001 Dutch travellers (the COMBAT study),2from November, 2012, to November, 2013. Acquisition was defined as the absence of ESBL-producing Enterobacteriaceae in a fecal swab...

The policy brief of the Ghana NHIS study is published on the INCLUDE-social protection website of NWO-WOTRO. The National Health Insurance Scheme (NHIS), initiated in 2004, aims to realize accessible quality healthcare services for the entire population of Ghana. While this mechanism has been successful in...

Resistance to tuberculosis (TB) drugs is a major public health problem threatening progress made in TB control worldwide. In some European and Central Asian countries, over 15 % of new and 50 % of previously treated TB cases have multidrug-resistant tuberculosis (MDR-TB) that cannot be treated with...